Method of inhibiting collagen formation by VDUP1 inhibition
AssigneeThe Trustees of Columbia University in the City of New York
InventorSilviu Itescu
Life of this patent
Estimating the term…
Abstract
This invention provides a method of treating a disorder of a subject's heart involving loss of cardiomyocytes which comprises administering to the subject an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart so as to thereby treat the disorder. This invention further provides the instant method wherein the agent is human endothelial progenitor cells, G-CSF, GM-CSF, SDF-1, and IL-8. This invention also provides methods of determining the susceptibility of a cardiomyocyte in a subject to apoptosis.
Claims1
A method of inhibiting collagen formation in a tissue, comprising contacting a tissue that has increased expression of Vitamin D3 Up-Regulated Protein-1 and which comprises fibroblasts with an amount of an inhibitor of Vitamin D3 Up-Regulated Protein-1 expression so as to inhibit expression of Vitamin D3 Up-Regulated Protein 1, thereby inhibiting collagen formation.
Dependencies are inferred from the claim text.